ConductScience.org, home

Paper36923535

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.

Starke L and 9 others. Theranostics, 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod. Papers, record 36923535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36923535

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.
PubMed
Journal
Theranostics
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2026-01-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Starke LLudger
2Millward JMJason M
3Prinz CChristian
4Sherazi FFatima
5Waiczies HHelmar
6Lippert CChristoph
7Nazaré MMarc
8Paul FFriedemann
9Niendorf TThoralf
10Waiczies SSonia

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple SclerosisMajor topic
Fluorine-19 Magnetic Resonance ImagingMajor topic
Multiple Sclerosis, Chronic ProgressiveMajor topic
Animals
Mice
Pharmaceutical Preparations
Magnetic Resonance Imaging
Sphingosine-1-Phosphate Receptors
Azetidines
Benzyl Compounds

Source PubMed

Download CSV of topics

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110617435An analytical derivation of a popular approximation of the Voigt function for quantification of NMR spectra.J Magn Reson2000https://conductscience.org/library/papers/10617435PubMed
234812528B1 inhomogeneity correction of RARE MRI at low SNR: Quantitative in vivo 19 F MRI of mouse neuroinflammation with a cryogenically-cooled transceive surface radiofrequency probe.Magn Reson Med2022https://conductscience.org/library/papers/34812528PubMed
311264465Metabolism of fluorine-containing drugs.Annu Rev Pharmacol Toxicol2001https://conductscience.org/library/papers/11264465PubMed
426794270From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.Nat Rev Drug Discov2016https://conductscience.org/library/papers/26794270PubMed
532722245Does Siponimod Exert Direct Effects in the Central Nervous System?Cells2020https://conductscience.org/library/papers/32722245PubMed
616767752High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo.Magn Reson Med2006https://conductscience.org/library/papers/16767752PubMed
723939898Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23939898PubMed
824639022Optimized three-dimensional sodium imaging of the human heart on a clinical 3T scanner.Magn Reson Med2015https://conductscience.org/library/papers/24639022PubMed
920842758Fluorine (19F) MRS and MRI in biomedicine.NMR Biomed2011https://conductscience.org/library/papers/20842758PubMed
1017969013Sparse MRI: The application of compressed sensing for rapid MR imaging.Magn Reson Med2007https://conductscience.org/library/papers/17969013PubMed
1129576505Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.Lancet2018https://conductscience.org/library/papers/29576505PubMed
1227990708
Temporal accumulation and localization of isoflurane in the C57BL/6 mouse and assessment of its potential contamination in 19 F MRI with perfluoro-crown-ether-labeled cardiac progenitor cells at 9.4 Tesla.
J Magn Reson Imaging2017https://conductscience.org/library/papers/27990708PubMed
1331821174Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury.JCI Insight2020https://conductscience.org/library/papers/31821174PubMed
1415509509The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.Mol Ther2004https://conductscience.org/library/papers/15509509PubMed
1533456555In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.Theranostics2021https://conductscience.org/library/papers/33456555PubMed
1624900670Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.ACS Med Chem Lett2013https://conductscience.org/library/papers/24900670PubMed
1723227121Image guided biodistribution and pharmacokinetic studies of theranostics.Theranostics2012https://conductscience.org/library/papers/23227121PubMed
1817627846Morphometric analysis of the C57BL/6J mouse brain.Neuroimage2007https://conductscience.org/library/papers/17627846PubMed
1934911793Siponimod Inhibits the Formation of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis.Neurol Neuroimmunol Neuroinflamm2022https://conductscience.org/library/papers/34911793PubMed
2027380540Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.JAMA Neurol2016https://conductscience.org/library/papers/27380540PubMed

See all 100 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42942759Drug Delivery Vehicle-Teriflunomide Interactions Affect Treatment and Fluorine Magnetic Resonance in an Animal Model of Multiple Sclerosis.Pharmaceutics2026https://conductscience.org/library/papers/42942759PubMed
41356192Translational molecular imaging and drug development in multiple sclerosis.Theranostics2026https://conductscience.org/library/papers/41356192PubMed
40993945FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic Applications.Curr Top Med Chem2026https://conductscience.org/library/papers/40993945PubMed
40182047Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma.Front Oncol2025https://conductscience.org/library/papers/40182047PubMed
38865057MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention.MAGMA2024https://conductscience.org/library/papers/38865057PubMed
37190232Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors.Cancers (Basel)2023https://conductscience.org/library/papers/37190232PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
S1PR11901PubTator's text mininghttps://conductscience.org/library/genes/1901NCBI Gene
S1PR553637PubTator's text mininghttps://conductscience.org/library/genes/53637NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36923535

GET https://conductscience.org/api/papers/v1/36923535/references?page=2